Contrast Echocardiogram
Links shared publicly online about this topic
GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms
news-medical.net — “GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison" (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing ha” View full resource at news-medical.net
Most Recently Shared on July 12, 2010 at 2:10 pm By:
GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms: GE Healthcar... http://bit.ly/czXEmp
Echocardiogram Detroit Michigan ~ Cardiac Ultrasound Exam
heartandveincenter.com — “An echocardiogram is usually performed to assess the heart size and function and the structure and function of the heart valves.” View full resource at heartandveincenter.com
Most Recently Shared on October 5, 2011 at 2:31 pm By:
GE Healthcare Medical Diagnostics Re-launches Optison™ Contrast Agent
medicalnewstoday.com — “GE Healthcare Medical Diagnostics announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent” View full resource at medicalnewstoday.com
Most Recently Shared on August 7, 2010 at 1:04 pm By:
MNT MRI / Ultrasound Health News
GE Healthcare Medical Diagnostics Re-launches Optison™ Contrast Agent http://mnt.to/3H7y #mri #pet #ultrasound
GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE
news-medical.net — “Today, GE Healthcare Medical Diagnostics announced results of a study that evaluated the cardiopulmonary safety of Optison- (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in improving suboptimal echocardiograms.” View full resource at news-medical.net
Most Recently Shared on June 14, 2011 at 7:44 am By:
GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE: Today, GE Healthcar... http://bit.ly/ixkMHO
GE Healthcare Medical Diagnostics Re-launches Optison" Contrast Agent - QualityPoint Technologies
qualitypointtech.net — “GE Healthcare Medical Diagnostics announced the market reintroduction of Optison" (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not” View full resource at qualitypointtech.net
Most Recently Shared on August 7, 2010 at 11:51 am By:
GE Healthcare Medical Diagnostics Re-launches Optisonâ„¢ Contrast Agent: GE Healthcare Medical Diagnostics announc... http://bit.ly/aiXcaP
ESC | Congresses | EUROECHO 2011 | Congress News | At echocardiography’s technological vanguard
escardio.org — “As an echocardiographer running one of Europe’s busiest imaging departments, Mark Monaghan has achieved many firsts. In addition to being the first UK centre to use commercial contrast agents, 3-D echo, and 3-D transoesophageal echo, his department - which performs 20,000 echocardiograms each year - introduced the first fully digital and networked echocardiography system in the country and contributed the 3-D imaging component of the first percutaneous aortic valve replacement.” View full resource at escardio.org
Most Recently Shared on December 9, 2011 at 11:40 am By:
European Cardiology Cardiology and Medical Society
At echocardiography’s technological vanguard http://t.co/zTTCA0cG #euroecho2011
GE's Optison re-enters U.S. market
healthimaging.com — “GE Healthcare Medical Diagnostics has reintroduced Optison (Perflutren Protein-Type A Microspheres Injectable Suspension), a diagnostic ultrasound contrast agent for use in select echocardiograms.” View full resource at healthimaging.com
Most Recently Shared on July 12, 2010 at 3:41 pm By:
Health Imaging & IT Health Magazine
GE's Optison re-enters U.S. market - GE Healthcare Medical Diagnostics has reintroduced Optison (Perflutren Protein... http://ow.ly/186jby
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Medical News from Around the World
-
Dr. Rodolfo Fahry
-
MNT MRI / Ultrasound
The latest MRI / PET / Ultrasound news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
